LMED (LataMed AI) Ending Cash Position: $0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMED LataMed AI Corp LMED
23 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is LataMed AI Ending Cash Position?

LataMed AI LMED -5.52% 23 Ending Cash Position is $0.00 Mil as of Jun. 2026. GuruFocus rates LMED with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

LataMed AI's Ending Cash Position for the quarter that ended in Jun. 2026 was $0.00 Mil.

LataMed AI Ending Cash Position Related Terms

LataMed AI Ending Cash Position Historical Data

* Premium members only.

The historical data trend for LataMed AI's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LataMed AI Ending Cash Position Chart

LataMed AI Annual Data
Trend Dec23 Dec24 Dec25
Ending Cash Position
0.00 0.00 0.00

LataMed AI Quarterly Data
Sep09 Sep10 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LMED
23GF Score
LataMed AI Corp LMED
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LataMed AI Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

LataMed AI's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0+0
=0.00

LataMed AI's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.00 Mil mean?
LataMed AI (LMED) has a Ending Cash Position of $0.00 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on LataMed AI and its competitors.
Is LataMed AI's Ending Cash Position too high?
LataMed AI's current Ending Cash Position is $0.00 Mil. Overall, LataMed AI has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's Ending Cash Position compare to RYDE and RDZN?
LataMed AI's Ending Cash Position of $0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Software company?
A good Ending Cash Position depends on the Software industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on LataMed AI and its competitors. LataMed AI's current Ending Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMED) has a current Ending Cash Position of $0.00 Mil. The current Ending Cash Position is $0.00 Mil. LataMed AI's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For LataMed AI (LMED), the current Ending Cash Position is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LataMed AI Business Description

Address Av. Romulo Gallegos con Av. Las Palmas, Edif. Torre Gerencial Los Andes, Caracas, VEN, 1071
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
23GF Score

Get the complete analysis for LMED

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price